A manufacturer of compact MRI machines that leverage AI to upgrade image quality has received FDA’s blessing to market its technology in the U.S.

The COVID crisis has spurred clinical researchers to look myriad ways AI might help win the war against the virus. Has the investigatory boomlet ended up raising as many nettlesome concerns as positive possibilities?

The FDA has cleared an AI tool that helps radiologists diagnose or rule out prostate cancer on MRI scans.

Several issues with AI can “make people suspicious” of the technology when applied to healthcare, according to the Consumer Technology Association.

International Business Machines Corp. is looking into dealing its AI-pioneering Watson Health unit so the parent can move more nimbly into cloud computing, the Wall Street Journal is reporting.

An Israeli AI startup has been cleared to market COVID-detecting voice analysis software in Europe, according to No Camels.

An AI startup’s virtual-patient technology is good enough at teaching empathy to clinicians that it’s already in use at Cedars-Sinai Medical Center in Los Angeles, the National Health Service in Britain and the University of Texas Medical Branch in Galveston.

The government of Saudi Arabia is bringing in Royal Philips to help the country of 35 million become a global leader in healthcare AI.